Additionally, we continue to actively pursue in-licensing opportunities for clinical-stage assets.” About RAPT Therapeutics, Inc. RAPT Therapeutics is a clinical-stage, immunology-based therapeutics ...
The U.S. Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
Sublingual Film pre-NDA meeting scheduled for fourth quarter 2024AQST-108 (epinephrine) Topical Gel pre-IND meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback